Read more
The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer.
List of contents
Preface.- Contributors.- Pathology and Classification of Thyroid Cancer.- Molecular Biology of Thyroid Cancer.- Thyroid Nodules.- Ultrasound Imaging and Thyroid Cancer.- Fine Needle Aspiration of the Thyroid.- Thyroid Cancer Staging.- Papillary Thyroid Carcinoma.- Follicular Thyroid Carcinoma.- Medullary Thyroid Carcinoma.- Anaplastic Thyroid Carcinoma.- Thyroid Lymphoma.- Surgical Management of Thyroid Cancer.- Radioactive Iodine Therapy.- External Beam Radiation Therapy in the Treatment of Differentiated Thyroid Cancers.- Targeted Therapies of Thyroid Cancer.
Summary
The American Cancer Society recently estimated that about 45,000 new cases of thyroid cancer will be diagnosed in the United States, with three-quarters occurring in women. The overall 5-year survival rate is about 97%, making it one of the least lethal cancers. We are experiencing an epidemic of well-differentiated thyroid cancer, in part due to the widespread use of imaging modalities that detect thyroid nodules and microcarcinomas. Concurrently, there have been a number of recent advances in surgical treatment, as well as diagnostic modalities that allow us to detect small amounts of residual local and metastatic disease. Additionally, a reexamination of past treatment regimens has led to new recommendations regarding the use of radioactive iodine, and to new therapeutic options, such as targeted therapy which have supplanted the use of more toxic chemotherapy for metastatic cancer. Multiple academic organizations have developed consensus guidelines for the management of thyroid cancer, occasionally with conflicting recommendations. In Thyroid Cancer, a renowned group of authors presents a broad overview of the pathology, pathophysiology, diagnosis, and management of thyroid cancer, with an emphasis on recent evidence-based information. State-of-the-art and a significant contribution to the literature, Thyroid Cancer is an invaluable reference for endocrinologists, oncologists, nuclear medicine physicians, radiation oncologists, primary care physicians, and surgeons who deal with head and neck cancer.
Additional text
From the reviews:
“The book is appropriate for practitioners involved in the care of patients with thyroid cancer, including internists, endocrinologists, surgeons, oncologists, radiologists, radiation oncologists, and pathologists. Students and housestaff officers with a particular interest in thyroid cancer also may find this book useful. … This is a comprehensive book on thyroid cancer with short and succinct chapters, making it very readable. It will be of interest to those who want to learn more about advances in thyroid cancer diagnosis and management.” (Rebecca L. Brown, Doody’s Review Service, March, 2012)
Report
From the reviews:
"The book is appropriate for practitioners involved in the care of patients with thyroid cancer, including internists, endocrinologists, surgeons, oncologists, radiologists, radiation oncologists, and pathologists. Students and housestaff officers with a particular interest in thyroid cancer also may find this book useful. ... This is a comprehensive book on thyroid cancer with short and succinct chapters, making it very readable. It will be of interest to those who want to learn more about advances in thyroid cancer diagnosis and management." (Rebecca L. Brown, Doody's Review Service, March, 2012)
